Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-24T03:18:55.859Z Has data issue: false hasContentIssue false
  • English
  • Français

Tratamiento auxiliar de topiramato en trastorno bipolar con ciclos ultradianos: caso clínico con seguimiento de 3 años

Published online by Cambridge University Press:  12 May 2020

Sherif Karama  and
Samarthji Lal
Sherif Karama
Affiliation:
Centro de Investigación del Hospital de Douglas, Universidad McGill, 6875 LaSalle Blvd., Verdun, Que., Canadá ,H4H 1R3
Samarthji Lal
Affiliation:
Centro de Investigación del Hospital Douglas, Universidad de McGill, 6875 LaSalle Blvd., Verdun, Que., CanadáH4H 1R3
Get access

Resumen

Un paciente con trastorno bipolar resistente al tratamiento y ciclos ultradianos respondió a un tratamiento auxiliar de topiramato. La respuesta se mantuvo durante un seguimiento de 3 años.

Keywords

Trastorno bipolarCiclos ultradianosTopiramato
Type
Caso clínico
Information
European Psychiatry (Ed. Española) , Volume 13 , Issue 8 , November 2006 , pp. 412 - 413
Copyright
Copyright © European Psychiatric Association 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Barrios, CChaudhry, TAGoodnick, PJ. Rapid cycling bipolar disorder. Expert Opin Pharmacother 2001;2:1963–73.CrossRefGoogle ScholarPubMed
Chengappa, RRathore, DLevine, JAtzert, RSolai, LParepally, H, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42–53.CrossRefGoogle ScholarPubMed
Evins, AE. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders. J Clin Psychiatr 2003;64(S8):9–14.Google ScholarPubMed
Hussain, MZ. Treatment of bipolar depression with topiramate. Eur Neuropsychopharmacol 1999;9(Suppl. 5):S222.CrossRefGoogle Scholar
Kusumakar, VYatham, LKutcher, SO'Donovan, C. Preliminary, open-label study of topiramate in rapid cycling bipolar women. Eur Neuropsychopharmacol 1999;9(Suppl. 5):S357.CrossRefGoogle Scholar
Letmaier, MSchreinzer, DWolf, RKasper, S. Topiramate as a mood stabilizer. Intem Clin Psychopharmacol 2001;16:295–8.CrossRefGoogle ScholarPubMed
Marcotte, D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Dis 1998;50:245–51.CrossRefGoogle ScholarPubMed
McElroy, SLSuppes, TKeck, PEFrye, MADenicoff, KDAltshuler, LL, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatr 2000;47:1025–33.CrossRefGoogle ScholarPubMed
Mclntyre, RSMancini, DAMcCann, SSrinivasan, JSagman, DKennedy, SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002;4:207–13.CrossRefGoogle Scholar
Vieta, ETorrent, CGarcia-Ribas, GGilabert, AGarcia-Pares, GRodriguez, A, et al. Use of topiramate in treatment-resistant bipolar spectrum disorders. J Clin Psychopharmacol 2002;22:431–5.CrossRefGoogle ScholarPubMed